FDA Approves Prostate Cancer Drug Jevtana - CBS News
Links shared publicly online about this topic.
- 1,077total visits
FDA Approves Prostate Cancer Drug Jevtana - CBS News
View full resource at cbsnews.com
Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, FDA
Most Recently Shared on June 21, 2010 at 8:28 pm By:
FDA Approves Prostate Cancer Drug Jevtana CBS News http://bit.ly/cljz6U
Gen-Probe receives FDA approval for PROGENSA PCA3 assay
news-medical.net — “DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high?value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.” View full resource at news-medical.net
Most Recently Shared on February 16, 2012 at 9:05 am By:
Genetics News: Gen-Probe receives FDA approval for PROGENSA PCA3 assay: DiagnoCure, Inc., a Quebec life sciences... http://t.co/odTzFYgG
Arrowhead receives FDA IND approval for Adipotide obesity drug
news-medical.net — “Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.” View full resource at news-medical.net
Most Recently Shared on January 5, 2012 at 10:32 am By:
Obesity News: Arrowhead receives FDA IND approval for Adipotide obesity drug: Arrowhead Research Corporation, a ... http://t.co/WtTufwQY
Pharma News, Pharma Industry, Pharmaceuticals Industry --- Fierce Pharma
fiercepharma.com — “Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.” View full resource at fiercepharma.com
Most Recently Shared on September 7, 2011 at 4:20 pm By:
J&J's prostate cancer pill Zytiga gets EMA's final OK. Joins Sanofi's Jevtana; maybe Provenge, eventually. http://t.co/1uxUU3Z $JNJ $SNY
Medical News: FDA Okays 6-Month Dose of Prostate Cancer Drug - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a six-month formulation of the prostate cancer drug leuprolide acetate for depot suspension (Lupron Depot).” View full resource at medpagetoday.com
Most Recently Shared on June 23, 2011 at 7:03 pm By:
FDA Okays 6-Month Dose of Prostate Cancer Drug http://bit.ly/jcylfx
Medical News: FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved” View full resource at medpagetoday.com
Most Recently Shared on June 9, 2011 at 9:02 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
FDA Warns of High-Grade Prostate Ca Risk with BPH Drugs: WASHINGTON -- The FDA has issued a warning of an increa... http://bit.ly/iODFem
Lab Notes: FDA Approves Zytiga for Advanced Prostate Cancer; Fox Respectfully Postpones Family Guy Hurricane | CalorieLab - Health News & Information Blog
calorielab.com — “Yesterday's top story: A new drug that allows men with advance prostate cancer live longer has been approved by the U.S. Food and Drug Administration.” View full resource at calorielab.com
Most Recently Shared on April 30, 2011 at 10:06 am By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Lab Notes: FDA Approves Zytiga for Advanced Prostate Cancer; Fox Respectfully Postpones Family Guy Hurricane (Ca... http://bit.ly/kudgqq
Medical News: FDA Okays New Drug for Advanced Prostate Ca - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved abiraterone acetate (Zytiga) for treatment of late-stage, castration-resistant prostate cancer as a combination therapy with prednisone in patients who have received” View full resource at medpagetoday.com
Most Recently Shared on April 29, 2011 at 4:55 pm By:
FDA Okays New Drug for Advanced Prostate Ca http://bit.ly/k4ZqIh
FDA Approves Advanced Prostate Cancer Drug - FoxNews.com
foxnews.com — “U.S. health regulators on Thursday approved a Johnson & Johnson (JNJ.N) drug for advanced prostate cancer considered one of the most important medicines that the company had been developing” View full resource at foxnews.com
Most Recently Shared on April 29, 2011 at 12:51 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
FDA Approves Advanced Prostate Cancer Drug: U.S. health regulators on Thursday approved a Johnson & Johnson (JNJ... http://fxn.ws/mwVnY8
FDA Approves Prostate Cancer Drug Zytiga | NewsBreakingOnline
newsbreakingonline.com — “The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy.” View full resource at newsbreakingonline.com
Most Recently Shared on April 29, 2011 at 8:37 am By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
FDA Approves Prostate Cancer Drug Zytiga (NewsBreakingOnline.com): The FDA has approved the Johnson & Johnson pi... http://bit.ly/ik6PMp
UPDATE 2-FDA approves J&J advanced prostate cancer drug | Reuters
reuters.com — “* To be sold under brand name Zytiga * Prolonged survival by 4 months in pivotal trial * Sales expected to exceed $1 billion (Adds sales projection, approval details, background) NEW YORK, April” View full resource at reuters.com
Most Recently Shared on April 28, 2011 at 7:51 pm By:
FDA approves J&J advanced prostate cancer drug http://bit.ly/mMYcsn
FDA approves orphan drug designation for Cytrx--™s INNO-206 to treat pancreatic cancer
news-medical.net — “CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved for orphan drug designation for the treatment of patients with pancreatic cancer by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA). CytRx holds the exclusive worldwide development and commercialization rights to INNO-206.” View full resource at news-medical.net
Most Recently Shared on April 28, 2011 at 6:40 pm By:
Prostate Cancer: FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer: CytRx Cor... http://bit.ly/mqBZ4e
FDA Approves Increased Production of Prostate Cancer Drug; Prostate Cancer News Today Provides Complete Coverage
einnews.com — “Published by EIN News, a service for global professionals.” View full resource at einnews.com
Most Recently Shared on March 11, 2011 at 2:39 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
FDA Approves Increased Production of Prostate Cancer Drug; Prostate Cancer News Today Provides Complete Coverage... http://bit.ly/elh1FJ
Adamis Pharmaceuticals Files IND for Product Candidate to Treat Prostate Cancer - News Press Release | PharmiWeb.com
pharmiweb.com — “Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that it has recently submitted to the FDA an Investigational New Drug (IND) application for APC-100 to treat prostate cancer (PCa). Following approval by the FDA of the IND, Adamis” View full resource at pharmiweb.com
Most Recently Shared on March 9, 2011 at 5:11 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Press Release: Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that it has recently submitted t... http://bit.ly/g32kgV
Medical News: FDA Denies BPH Drug for Prostate Cancer Prevention - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA failed to approve an indication for the benign prostatic hyperplasia (BPH) drug dutasteride (Avodart) for use in prostate cancer prevention.” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2011 at 12:37 am By:
FDA Denies BPH Drug for Prostate Cancer Prevention http://bit.ly/hG5xZB
Medical News: FDA Denies BPH Drug for Prostate Cancer Prevention - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA failed to approve an indication for the benign prostatic hyperplasia (BPH) drug dutasteride (Avodart) for use in prostate cancer prevention.” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2011 at 12:00 am By:
FDA Denies BPH Drug for Prostate Cancer Prevention http://bit.ly/efdSTp
Advertisement
